JP2020505352A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020505352A5 JP2020505352A5 JP2019538525A JP2019538525A JP2020505352A5 JP 2020505352 A5 JP2020505352 A5 JP 2020505352A5 JP 2019538525 A JP2019538525 A JP 2019538525A JP 2019538525 A JP2019538525 A JP 2019538525A JP 2020505352 A5 JP2020505352 A5 JP 2020505352A5
- Authority
- JP
- Japan
- Prior art keywords
- alpha
- asn
- phe
- trp
- lys
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022193564A JP2023014346A (ja) | 2017-01-18 | 2022-12-02 | インターロイキン－２３受容体のペプチド阻害剤および炎症性疾患を治療するためのそれらの使用 |
| JP2025088409A JP2025162551A (ja) | 2017-01-18 | 2025-05-28 | インターロイキン－２３受容体のペプチド阻害剤および炎症性疾患を治療するためのそれらの使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762447778P | 2017-01-18 | 2017-01-18 | |
| US62/447,778 | 2017-01-18 | ||
| PCT/US2018/014257 WO2018136646A1 (en) | 2017-01-18 | 2018-01-18 | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022193564A Division JP2023014346A (ja) | 2017-01-18 | 2022-12-02 | インターロイキン－２３受容体のペプチド阻害剤および炎症性疾患を治療するためのそれらの使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020505352A JP2020505352A (ja) | 2020-02-20 |
| JP2020505352A5 true JP2020505352A5 (enExample) | 2021-02-25 |
Family
ID=62908287
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019538525A Withdrawn JP2020505352A (ja) | 2017-01-18 | 2018-01-18 | インターロイキン−２３受容体のペプチド阻害剤および炎症性疾患を治療するためのそれらの使用 |
| JP2022193564A Pending JP2023014346A (ja) | 2017-01-18 | 2022-12-02 | インターロイキン－２３受容体のペプチド阻害剤および炎症性疾患を治療するためのそれらの使用 |
| JP2025088409A Pending JP2025162551A (ja) | 2017-01-18 | 2025-05-28 | インターロイキン－２３受容体のペプチド阻害剤および炎症性疾患を治療するためのそれらの使用 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022193564A Pending JP2023014346A (ja) | 2017-01-18 | 2022-12-02 | インターロイキン－２３受容体のペプチド阻害剤および炎症性疾患を治療するためのそれらの使用 |
| JP2025088409A Pending JP2025162551A (ja) | 2017-01-18 | 2025-05-28 | インターロイキン－２３受容体のペプチド阻害剤および炎症性疾患を治療するためのそれらの使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20200207822A1 (enExample) |
| EP (1) | EP3570864A4 (enExample) |
| JP (3) | JP2020505352A (enExample) |
| AU (1) | AU2018210174B2 (enExample) |
| CA (1) | CA3049889A1 (enExample) |
| WO (1) | WO2018136646A1 (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT2968443T (pt) | 2013-03-15 | 2021-12-28 | Protagonist Therapeutics Inc | Análogos de hepcidina e seus usos |
| SG10201810321PA (en) | 2014-05-16 | 2018-12-28 | Protagonist Therapeutics Inc | α4β7 INTEGRIN THIOETHER PEPTIDE ANTAGONISTS |
| ES2977537T3 (es) | 2014-07-17 | 2024-08-26 | Protagonist Therapeutics Inc | Inhibidores peptídicos orales del receptor de interleucina-23 y su uso para tratar enfermedades inflamatorias intestinales |
| US10301371B2 (en) | 2014-10-01 | 2019-05-28 | Protagonist Therapeutics, Inc. | Cyclic monomer and dimer peptides having integrin antagonist activity |
| SG11201702553RA (en) | 2014-10-01 | 2017-04-27 | Protagonist Therapeutics Inc | NOVEL α4β7 PEPTIDE MONOMER AND DIMER ANTAGONISTS |
| US10787490B2 (en) | 2015-07-15 | 2020-09-29 | Protaganist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| WO2017117411A1 (en) | 2015-12-30 | 2017-07-06 | Protagonist Therapeutics, Inc. | Analogues of hepcidin mimetics with improved in vivo half lives |
| AU2017273857B2 (en) | 2016-06-01 | 2021-08-19 | Athira Pharma, Inc. | Compounds |
| EP4092038A1 (en) | 2017-09-11 | 2022-11-23 | Protagonist Therapeutics, Inc. | Opioid agonist peptides and uses thereof |
| EP4501952A3 (en) | 2018-02-08 | 2025-04-16 | Protagonist Therapeutics, Inc. | Conjugated hepcidin mimetics |
| EP3997105A4 (en) * | 2019-07-10 | 2023-09-13 | Protagonist Therapeutics, Inc. | PEPTIDE INHIBITORS OF THE INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY DISEASES |
| TW202116793A (zh) * | 2019-07-10 | 2021-05-01 | 美商領導醫療有限公司 | 介白素-23受體之肽抑制劑及其於治療發炎疾病的用途 |
| CN115279782A (zh) | 2020-01-15 | 2022-11-01 | 詹森生物科技公司 | 白介素-23受体的肽抑制剂及其用于治疗炎性疾病的用途 |
| IL294680A (en) * | 2020-01-15 | 2022-09-01 | Janssen Biotech Inc | Peptide inhibitors of the interleukin-23 receptor and their use for the treatment of inflammatory diseases |
| IL302996B2 (en) | 2020-11-20 | 2025-04-01 | Janssen Pharmaceutica Nv | Compositions of interleukin-23 receptor peptide inhibitors |
| EP4370531A4 (en) * | 2021-07-14 | 2025-09-03 | Janssen Biotech Inc | PEPTIDE INHIBITORS OF THE INTERLEUKIN-23 RECEPTOR |
| AU2022311814A1 (en) | 2021-07-14 | 2024-02-29 | Janssen Biotech, Inc. | Lipidated peptide inhibitors of interleukin-23 receptor |
| CA3240982A1 (en) | 2021-12-01 | 2023-06-08 | Zealand Pharma A/S | Peptide inhibitors of interleukin-23 receptor |
| JP2025521647A (ja) | 2022-06-30 | 2025-07-10 | サノフイ | 選択的ｉｌ－２３受容体アンタゴニストとしての新規ペプチド |
| JP2025523026A (ja) * | 2022-07-14 | 2025-07-17 | ヤンセン ファーマシューティカ エヌ．ベー． | Ｉｌ－２３の環状ペプチド阻害剤 |
| KR20250135270A (ko) * | 2023-01-16 | 2025-09-12 | 얀센 파마슈티카 엔브이 | 인터류킨-23 수용체의 지질화된 펩티드 억제제의 제형 |
| EP4471048A1 (en) | 2023-06-01 | 2024-12-04 | Zealand Pharma A/S | Peptide inhibitors of interleukin-23 receptor |
| EP4471049A1 (en) | 2023-06-01 | 2024-12-04 | Zealand Pharma A/S | Peptide inhibitors of interleukin-23 receptor |
| WO2025051912A1 (en) | 2023-09-08 | 2025-03-13 | Sanofi | New peptides as selective il-23 receptor inhibitors |
| WO2025051920A1 (en) | 2023-09-08 | 2025-03-13 | Sanofi | New peptides as selective il-23 receptor inhibitors |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030166138A1 (en) * | 2002-02-21 | 2003-09-04 | Todd Kinsella | Cyclic peptides and analogs useful to treat allergies |
| EA017849B1 (ru) | 2007-02-15 | 2013-03-29 | Индиана Юниверсити Рисерч Энд Текнолоджи Корпорейшн | Соагонисты глюкагоновых/glp-1-рецепторов |
| CA2707840A1 (en) | 2007-08-20 | 2009-02-26 | Allozyne, Inc. | Amino acid substituted molecules |
| US8946150B2 (en) | 2011-06-14 | 2015-02-03 | Medical Diagnostic Laboratories, LLC. | Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof |
| US9605027B2 (en) * | 2011-06-14 | 2017-03-28 | Medical Diagnostic Laboratories, Llc | Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof |
| ES2977537T3 (es) * | 2014-07-17 | 2024-08-26 | Protagonist Therapeutics Inc | Inhibidores peptídicos orales del receptor de interleucina-23 y su uso para tratar enfermedades inflamatorias intestinales |
| CN108348580B (zh) * | 2015-07-15 | 2022-05-10 | 领导医疗有限公司 | 白细胞介素-23受体的肽抑制剂以及其治疗炎症性疾病的用途 |
| WO2018089693A2 (en) * | 2016-11-09 | 2018-05-17 | Protagonist Therapeutics, Inc. | Methods for determining and monitoring gastrointestinal inflammation |
-
2018
- 2018-01-18 WO PCT/US2018/014257 patent/WO2018136646A1/en not_active Ceased
- 2018-01-18 JP JP2019538525A patent/JP2020505352A/ja not_active Withdrawn
- 2018-01-18 CA CA3049889A patent/CA3049889A1/en active Pending
- 2018-01-18 EP EP18741939.5A patent/EP3570864A4/en active Pending
- 2018-01-18 US US16/478,733 patent/US20200207822A1/en not_active Abandoned
- 2018-01-18 AU AU2018210174A patent/AU2018210174B2/en active Active
-
2022
- 2022-12-02 JP JP2022193564A patent/JP2023014346A/ja active Pending
-
2023
- 2023-01-13 US US18/097,077 patent/US20240132558A1/en active Pending
-
2025
- 2025-05-28 JP JP2025088409A patent/JP2025162551A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020505352A5 (enExample) | ||
| JP7403507B2 (ja) | 薬物としてアマトキシンの誘導体を有する抗体薬物コンジュゲート | |
| US20240173427A1 (en) | Glypican 3 antibodies and conjugates thereof | |
| JP2015533833A5 (enExample) | ||
| JP2018522008A5 (enExample) | ||
| CN106456608B (zh) | 抗her2抗体-美登木素缀合物及其使用方法 | |
| JP2023139158A5 (enExample) | ||
| JP2016518351A5 (enExample) | ||
| JP2010530849A5 (enExample) | ||
| JP2017530090A5 (enExample) | ||
| CN111741771A (zh) | 特异于epha2的双环肽配体 | |
| JP2017522362A5 (enExample) | ||
| WO2015155976A1 (ja) | 抗ｈｅｒ２抗体－薬物コンジュゲート | |
| JP7109613B2 (ja) | 抗ｃｄ２２抗体－メイタンシンコンジュゲートおよびその使用方法 | |
| CN114502201A (zh) | 靶向性树枝状体缀合物 | |
| JPS60156700A (ja) | トリペプチド化合物、その製造法および医薬組成物 | |
| JP2024012517A5 (enExample) | ||
| JPWO2020014646A5 (enExample) | ||
| JPWO2021146454A5 (enExample) | ||
| JP2025508779A (ja) | 抗体及びその薬物コンジュゲート並びに用途 | |
| IL299778A (en) | Therapeutic use of glucagon derivative or conjugate thereof for liver disease | |
| AU2020376910A1 (en) | Anti-CD37 antibody-maytansine conjugates and methods of use thereof | |
| JPWO2020037434A5 (enExample) | ||
| JP2025538297A (ja) | 環状ペプチドの合成 | |
| CN118852343A (zh) | 一种多肽化合物、其配合物及应用 |